Netherlands · Record · Brief regering
2024Z06459
Response to the committee's request for a copy of the letter to the patient association 'Muscle Diseases Netherlands' about the request for widespread availability of the drug Evrysdi (risdiplam) against the muscle disease spinal muscular atrophy (SMA)
Introduced
12 April 2024
Last action
—
Status
Afgedaan
Sponsors
—
Subjects
Discovery layer
Source updated
20 June 2024
Summary
Response to the committee's request for a copy of the letter to the patient association 'Muscle Diseases Netherlands' about the request for widespread availability of the drug Evrysdi (risdiplam) against the muscle disease spinal muscular atrophy (SMA)
Machine translation from Dutch. The official text remains authoritative.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Reactie op verzoek commissie over een afschrift van de brief aan de patiëntenvereniging ‘Spierziekten Nederland’ over het verzoek tot brede beschikbaarheid van het geneesmiddel Evrysdi (risdiplam) tegen de spierziekte spinale musculaire atrofie (SMA)
Response to verzoek commissie on a afschrift van de brief aan de patiëntenvereniging ‘Spierziekten Nederland’ on the verzoek tot brethe availability of het geneesmiddel Evrysdi (risdiplam) tegen de spierziekte spinale musculaire atrofie (SMA)
Brief regering · NL · 11 April 2024
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.